Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Política de privacidad

Inicio Explorar nav.journalClub Tendencias

⌘+K

Adjuvant Chemotherapy Using the FOLFOX Regimen in Colon Cancer | Synapse

January 1, 2011Open Access

Adjuvant Chemotherapy Using the FOLFOX Regimen in Colon Cancer

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Postoperative chemotherapy using the FOLFOX regimen, oxaliplatin in combination with 5-fluorouracil and leucovorin, is effective and tolerable in patients with stage III and high-risk stage II colon cancer.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Jeon et al. (Sat,) studied this question.

synapsesocial.com/papers/69d7cd3961e2ce1627d1813c https://doi.org/https://doi.org/10.3393/jksc.2011.27.3.140

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial2009 · 2,293 citations
2Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer2004 · 3,661 citations
3Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: Data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C898032011 · 111 citations
4Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years.2004 · 165 citations
5Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 20082011 · 231 citations